Blog - FreeMind Group

Everybody 12 /Case Studies 0 /Conferences 10 /FreeMind Elite 0 /FreeMind Elite 2024 0 /FreeMind Elite 2025 0 /Job posting 0 /NDFS 2025 Presentations 0 /NDFS 2026 Presentations 0 /News 1 /Opinions 0 /Opportunities 1 /Presentations 0 /Uncategorized 0 /Webinars 1

Non-dilutive funding leads to equity investment — How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare
August 29, 2022/by Ayal Ronen

BioFuture, November 7-9, 2022, NYC — Biofuture, a Demy-Colton Event
August 2, 2022/by Ayal Ronen

HealthTech Investment Forum, September 20-22, 2022, in Basel — The HealthTech Investment Forum & Biotech in Europe Forum, Sept. 20-22, Basel
July 20, 2022/by Ayal Ronen

ATE 2022 FMC banner — Advanced Therapies Europe, Aug. 31-Sept. 1, London
July 14, 2022/by Ayal Ronen

Redefining Early Stage Funding Conference, Boston, September 21-23 — RESI Boston, Sept. 21-23
July 4, 2022/by Ayal Ronen

MEDFIT 2022 Sept 20-21 Grenoble France — MedFIT, Sept. 21-22, Grenoble, France
July 3, 2022/by Ayal Ronen

LSX Nordic September 6-7, 2022, In-Person in Copenhagen — LSX Nordic Congress, Sept. 2022 (Copenhagen)
July 3, 2022/by Ayal Ronen

OCTS Banner cropped — Kisaco Onco Cell Therapy Summit, June 29-30, 2022 (Boston)
May 2, 2022/by Ayal Ronen

immuno-oncology innovation forum, May 24-25, 2022, by Sachs Associates — Immuno-Oncology Innovation Forum, May 24-25, 2022 (online)
April 28, 2022/by Ayal Ronen

Digital RESI June 7-9, 2022 — Digital RESI, June 7-9, 2022 (online)
April 28, 2022/by Ayal Ronen

LSX World Congress USA 2022 June 21-22 — LSX World Congress USA, June 21-22, 2022 (Boston)
April 28, 2022/by Ayal Ronen

$7.245 Billion in Funding Opportunities for Cancer Research. Join our webinar to fund out more. — Webinar: $7+ Billion in Cancer Research Funding Opportunities 2022
April 20, 2022/by Ayal Ronen

Reach out to us with your non-dilutive funding requirements

Contact us Who we are

Subscribe to our Newsletter